How long before you feel the effects of semaglutide?

Appetite suppression is often the earliest signal — many people report feeling fuller sooner within the first two weeks.
Measurable weight loss generally becomes visible on the scales from weeks four to eight onward, as the dose increases.
The most significant results in trials accumulated over 52 to 68 weeks, not in the first month.
Individual response varies; how quickly effects appear depends on dose, lifestyle factors, and how your body tolerates each step up.

Most people begin to notice semaglutide's effects within the first one to four weeks of treatment, though meaningful weight loss typically builds over several months. The STEP 1 trial, published in the New England Journal of Medicine, found that participants taking 2.4mg semaglutide lost an average of around 15% of their body weight over 68 weeks — a result that reflects a gradual, cumulative process rather than a sudden change. Semaglutide is a prescription-only medicine, and a prescriber will assess whether it is suitable for you before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence and clinical guidance tell us about semaglutide's timeline

What the trial data shows about the early weeks

The STEP 1 trial is the clearest window we have into semaglutide's timeline. Over 68 weeks, adults with obesity taking 2.4mg semaglutide alongside lifestyle support achieved an average weight reduction of approximately 15%, compared with around 2.4% in the placebo group. What the headline figure doesn't show is the shape of that journey: weight loss started slowly, picked up as the dose was increased, and continued accumulating well past the six-month mark.

In the early weeks, the effects people notice first are not always about weight at all. Reduced appetite, a faster sense of fullness after smaller portions, and sometimes a shift in how much certain foods appeal to you, these are the GLP-1 receptor effects working before the scales have much to report. For some people, nausea or mild digestive discomfort appears in the same window. This is common and usually settles as the body adjusts, particularly if the dose is kept low at the start.

The starting dose of 0.25mg is specifically designed to give the body time to adapt, not to produce rapid weight loss. Expecting dramatic results at this stage sets the wrong benchmark. Patience in the early weeks is genuinely part of how the medicine works.

Why the dose schedule shapes how quickly you feel results

Semaglutide reaches what pharmacologists call steady-state blood levels after about four to five weeks of weekly injections. That matters because the therapeutic effect tracks those levels, the fuller appetite suppression tends to emerge once the medicine has been present consistently, not after the first or second injection alone.

The licensed titration pathway moves through 0.25mg, 0.5mg, 1.0mg, 1.7mg, and then 2.4mg, with roughly four weeks at each level guided by the prescriber. Many people report that the shift from the lower starter doses to the mid-range doses is when the effect becomes noticeably stronger. That step usually falls somewhere around weeks eight to twelve for those who tolerate each increase well.

Understanding this rhythm helps set realistic expectations. The NHS semaglutide medicines page explains the titration schedule clearly and is worth bookmarking alongside your treatment. A prescriber (not a fixed rule) decides the pace of increases based on how you are tolerating each dose.

How long before weight loss becomes consistent

For most people, consistent, week-on-week weight loss becomes more predictable from around month three onwards, once a meaningful therapeutic dose is in place. Before that, the pattern can feel uneven: a good week followed by a plateau, then movement again. This is normal and reflects the body's adaptation, not a sign the medicine is failing.

Protein intake, hydration, and regular movement all influence how well the medicine's appetite effects translate into fat loss rather than muscle loss. These are not add-ons; the trial evidence was collected alongside lifestyle support. A prescriber or dietitian can help you think through what that looks like practically, keeping a routine helps, whether that means your injection on the same evening each week, stored in the fridge door where you'll see it.

If you're thinking about what to expect over the longer term, the page on how long Wegovy takes to work covers the full treatment arc in detail, and our Wegovy treatment guide explains eligibility and the overall programme.

When to speak to a prescriber if the effects aren't what you expected

There is a meaningful difference between a slow start (which is expected) and a medicine that genuinely isn't working for you. The NICE appraisal of semaglutide (TA875) notes that if less than 5% weight loss has occurred after six months at the maintenance dose, continuing treatment should be reviewed. That review is a clinical conversation, not an automatic stop.

Separately, there are symptoms that need prompt attention at any point: severe stomach pain that spreads to your back, persistent vomiting preventing you from keeping fluids down, or signs of an allergic reaction. These are not about slow effects, they are reasons to seek medical help without delay and to report the experience via the MHRA Yellow Card scheme.

If you have questions about your individual response, or you're wondering whether semaglutide is right for you in the first place, our prescribers are available seven days a week. Many patients also find it helpful to read about how long it takes to feel the effects of Wegovy, understand how long before you feel the effects of Wegovy at each dose stage, and get a clearer picture of how long until the effects of Wegovy become noticeable for most people. You can read more about how Wegovy may affect blood test results if that is also on your mind, or explore weight-loss treatment options more broadly. When you're ready, speak to our prescribers through a free consultation, a real clinician reads your answers the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions